Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma

Keyphrases

• Malignant Melanoma 100%
• Immune Response 100%
• Autologous Tumors 100%
• Antitumor 100%
• Cytolytic 100%
• Tumor Targeting 100%
• Allogeneic 100%
• Melanoma Tumor Cells 100%
• Tumor 50%
• Melanoma 50%
• Tumor-associated 50%
• T Cells 50%
• Lysis 50%
• Tumor-infiltrating Lymphocytes 50%
• Metastatic Melanoma 50%
• Human Lymphocytes 50%
• Recombinant interleukin-2 50%
• Natural Killer Cells 50%
• Adoptive Immunotherapy 50%
• Tumor-initiating Cells 50%
• Limited Capacity 50%

Immunology and Microbiology

• Immune Response 100%
• Tumor Cell 100%
• T Cell 50%
• Lymphocyte 50%
• Recombinant Interleukin 2 50%
• Adoptive Immunotherapy 50%
• Tumor-Infiltrating Lymphocytes 50%
• Killer Cell 50%

Medicine and Dentistry

• Neoplasm 100%
• Nodular Melanoma 100%
• Immune Response 100%
• Tumor Cell 28%
• Lymphocyte 14%
• T Cell 14%
• Tumor Infiltrating Lymphocyte 14%
• Recombinant Interleukin 2 14%
• Adoptive Immunotherapy 14%
• Killer Cell 14%